A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
Mark Pauly, Peter Zweifel
Roger Feldman, Douglas Wholey
John A. Nyman, Roland Maude-Griffin
Bradley Herring, Mark V. Pauly
János Kornai, Karen Eggleston
scroll for more
use your arrow keys for more
scroll or use arrow keys for more